Literature DB >> 8206040

Summary of papers and research recommendations of Working Group on Tropospheric Ozone, Health Effects Institute environmental epidemiology planning project.

I B Tager1.   

Abstract

This paper summarizes the themes and recommendations that emerge from the papers presented by the Working Group on Tropospheric Ozone. In terms of current knowledge, the following are considered of particular importance: a) lack of clear evidence for a human analogue of the terminal bronchiolar and proximal acinar changes observed in the lungs of ozone-exposed animals; b) lack of evidence for a connection between the acute respiratory effects of O3 and possible chronic respiratory effects; c) need to better define the characteristics of O3-susceptible individuals; d) the lack of adequate exposure assessment tools for reconstruction of lifetime O3 exposure; and e) incomplete information on the role of other ambient environmental pollutants in the facilitation of O3 effects or as a cause of effects attributed to O3 in human populations. Based on the above, several recommendations for epidemiologic research on health effects of O3 are offered. a) Studies to investigate the existence of chronic health effects of O3 are essential, particularly those that include autopsied human lung tissue and biologic and physiologic response markers. b) Studies are needed to link acute responses with chronic effects and should include joint epidemiologic and controlled-exposure assessments. c) Studies are needed to identify susceptible subgroups. Such studies should include newly emerging biologic markers of O3 exposure. d) Accurate and precise tools for chronic O3 exposure assessment need to be developed for use in retrospective and prospective studies. e) Collaborative studies between epidemiologists and laboratory investigators are needed to develop and evaluate markers of O3 exposure and to test O3 exposure models.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8206040      PMCID: PMC1519692          DOI: 10.1289/ehp.93101s4237

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  9 in total

Review 1.  Health indices of the adverse effects of air pollution: the question of coherence.

Authors:  D V Bates
Journal:  Environ Res       Date:  1992-12       Impact factor: 6.498

Review 2.  Assessing exposures to inhaled complex mixtures.

Authors:  B P Leaderer; P J Lioy; J D Spengler
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 3.  Detection of chronic respiratory bronchiolitis in oxidant-exposed populations: analogy to tobacco smoke exposure.

Authors:  D V Bates
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

4.  Introduction to working group on tropospheric ozone, Health Effects Institute environmental epidemiology planning project.

Authors:  I B Tager
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

5.  Design and analysis of studies of the health effects of ozone.

Authors:  A Muñoz
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

6.  Examining acute health outcomes due to ozone exposure and their subsequent relationship to chronic disease outcomes.

Authors:  B D Ostro
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

7.  The role of ozone exposure in the epidemiology of asthma.

Authors:  J R Balmes
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

8.  Use of human lung tissue for studies of structural changes associated with chronic ozone exposure: opportunities and critical issues.

Authors:  M Lippmann
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

9.  Identification of subpopulations that are sensitive to ozone exposure: use of end points currently available and potential use of laboratory-based end points under development.

Authors:  R B Devlin
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.